Women with large uterine fibroids delivered at an earlier gestational age compared to women with small or no fibroids. Blood loss and rate of blood transfusion were also increased.
Results from previous studies investigating the potential association between surgical menopause due to bilateral oophorectomy and increased mortality are mixed. Bilateral oophorectomy was not associated with increased mortality in the California Teachers Study.
Associations of childbearing history with all-cause and cardiovascular disease (CVD) mortality in postmenopausal women were examined. High gravidity was associated with reduced CVD and non–coronary heart disease CVD mortality, independent of covariates.
Women with malignant disease have a significantly lower oocyte retrieval rate compared with agematched healthy controls; specific malignancy or stage effect on ovarian response to stimulation cannot be assessed.
Measures of ovarian reserve are impaired among cancer survivors compared with unexposed females of similar age. The degree of impairment is dependent on the toxicity of the previous treatment.
The prevalence of NR5A1 mutations in a large cohort of well-phenotyped women with secondary amenorrhea and diagnosed with POI was only 1.4%, which is substantially lower than previously reported.
The examination of 66 in vitro fertilization–conceived children and 69 control children revealed no imprinting abnormalities at H19, KCNQ1OT1, SNRPN, or IGF2. Satellite 2 methylation was normal, and no global changes in methylation were detected.
Few predictors contribute to the variability seen in chemotherapy-related amenorrhea (CRA) among premenopausal women with breast cancer; later age at menarche and smoking increase the odds of CRA.
A comprehensive approach to women with severe Asherman syndrome and amenorrhea is outlined including standardized preoperative, operative, and postoperative care. All women resumed menses, and 50% conceived after treatment.
Polydeoxyribonucleotide administration in experimental varicocele improved testicular angiogenesis. This event might imply an augmented oxygen supply, a subsequent balance of the apoptotic mechanism, and an improvement of spermatogenesis.
The effects of tinzaparin and enoxaparin on decidual cells were evaluated. Tinzaparin induced heparinbinding epidermal growth factor–like growth factor expression and secretion. Both low-molecular-weight heparins prevented tumor necrosis factor (TNF) a–induced apoptosis of decidual cells.
Androgens inhibit cell death of decidualizing endometrial stromal cells exposed to oxidative stress signals. Therefore, androgens might play a critical role for decidua processes of embryo implantation and trophoblast invasion.
Ezrin/phospho-ezrin immunoreactivity are present on apical surfaces of the luminal epithelium, around secretory vacuoles and in luminal secretions during the secretory phase. These findings have functional implications for implantation biology.
Immature testicular tissue is more sensitive and shows differential cell-specificity to cryoprotectants. Dimethyl sulfoxide and ethylene glycol are ideal cryoprotectants for immature and adult testicular tissue, respectively.
We have compared open vs. closed systems for mouse and human blastomere vitrification and conclude that the closed system is more efficient in terms of blastomere survival and division.
Lowering of androgens and insulin during pregnancy in mothers with polycystic ovary syndrome reduces anti-Mullerian hormone levels in their daughters, which might reflect a decrease in their follicular mass.
Women with polycystic ovary syndrome have six-fold greater odds of generalized anxiety symptoms compared with control women, suggesting the need to routinely screen for anxiety symptoms.
Treatment with gonadotropin-releasing hormone antagonist improved the clinical, laboratory and ultrasonographic parameters of a pituitary adenoma secreting follicle-stimulating hormone associated with ovarian hyperstimulation which persisted after transsphenoidal surgery.
Patients with polycystic ovary syndrome seem to have thicker femoral cartilage than normal healthy women, but the increase does not correlate with the patients’ clinical parameters.
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
Cookie Control
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us
and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.